InvestorsHub Logo
Followers 17
Posts 1062
Boards Moderated 0
Alias Born 07/20/2010

Re: scratchy post# 315

Monday, 03/18/2024 2:10:15 PM

Monday, March 18, 2024 2:10:15 PM

Post# of 324
Probably run up to FDA decision in April 2024.

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
https://finance.yahoo.com/news/pharmather-provides-priority-original-abbreviated-130000660.html

Fabio Chianelli, CEO of PharmaTher, commented: “We believe 2024 will be a transformative year for PharmaTher with the expected FDA approval of ketamine having an assigned goal date for approval on April 29, 2024. In anticipation of a potential FDA approval, we are focusing on the commercial scale-up of ketamine in the U.S. and seeking additional international approvals.”